β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor

BACKGROUND: Prostate cancer is a common and heterogeneous disease, where androgen receptor (AR) signaling plays a pivotal role in development and progression. The initial treatment for advanced prostate cancer is suppression of androgen signaling. Later on, essentially all patients develop an androg...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gluschnaider, Udi, Hidas, Guy, Cojocaru, Gady, Yutkin, Vladimir, Ben-Neriah, Yinon, Pikarsky, Eli
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2010
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2816705/
https://ncbi.nlm.nih.gov/pubmed/20140206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0009060
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak